(Q81867421)

English

Treatment of a patient with a nodal peripheral T-cell lymphoma (angioimmunoblastic T-Cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4)

scientific article published on 01 January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Treatment of a patient with a nodal peripheral T-cell lymphoma (angioimmunoblastic T-Cell lymphoma) with a human monoclonal antibody against the CD4 antigen (HuMax-CD4) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

angioimmunoblastic T-cell lymphoma

1 reference

based on heuristic

inferred from title

author name string

H Hagberg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

M Pettersson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

T Bjerner

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

G Enblad

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

191-194

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15965283%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

https://scigraph.springernature.com/pub.10.1385/mo:22:2:191

0 references

Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angioimmunoblastic T-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15965283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81867421&oldid=1619787236"